VanishPoint® syringe sales have historically comprised most of our sales. VanishPoint® syringe sales were 89.9%, 84.9%, and 85.6% of our revenues in 2017, 2018, and 2019. As we have previously ...

A jury awarded Retractable Technologies Inc. more than $113 million after it determined a competitor attempted to obtain a monopoly in the plastic safety syringe market. Retractable Technologies sued ...

Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed ...

Retractable Technologies (NYSE:RVP) its VanishPoint safety syringes are not part of a safety advisory issued by the FDA on Thursday about suspected performance problems with certain syringes ...

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2018. Further details concerning the ...

A federal judge has ordered Becton Dickinson & Co. to pay $340 million to Retractable Technologies, Inc. (RVP) in a long-running dispute over the smaller company's allegations of false advertising. In ...

These 16.4 million syringes include the 11.9 million units discussed in Retractables 10-Q for the quarterly period ended September 30 th, 2006. Retractable received its first contract through the ...

agkorce Nigeria Limited has launched the MK VanishPoint Retractable Syringes and Needles. These modern medical apparatus were being introduced into Africa’s largest economic for the first time. The MK ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more.

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2019. Further details concerning the ...